This narrative review, published in Osteoporosis International (2020), examines the role of menopausal hormone therapy (MHT) in managing postmenopausal osteoporosis. The study highlights that MHT provides significant anti-fracture efficacy in women not specifically selected for low bone mineral density, with benefits observed regardless of concurrent progestogen use. However, these skeletal
